JP2019505538A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019505538A5 JP2019505538A5 JP2018542227A JP2018542227A JP2019505538A5 JP 2019505538 A5 JP2019505538 A5 JP 2019505538A5 JP 2018542227 A JP2018542227 A JP 2018542227A JP 2018542227 A JP2018542227 A JP 2018542227A JP 2019505538 A5 JP2019505538 A5 JP 2019505538A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- carrier solution
- carrageenan
- amount
- kappa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000243 solution Substances 0.000 claims 12
- 239000000969 carrier Substances 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 10
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2R,3S,4R,5R,6S)-6-[[(1R,3S,4R,5R,8S)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1R,3R,4R,5R,8S)-8-[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 claims 7
- 239000003795 chemical substances by application Substances 0.000 claims 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- 206010039085 Rhinitis allergic Diseases 0.000 claims 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N Xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 2
- 229960002675 Xylitol Drugs 0.000 claims 2
- 230000000172 allergic Effects 0.000 claims 2
- 201000010105 allergic rhinitis Diseases 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 230000000843 anti-fungal Effects 0.000 claims 2
- 230000003110 anti-inflammatory Effects 0.000 claims 2
- 230000000840 anti-viral Effects 0.000 claims 2
- 230000003078 antioxidant Effects 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- 230000003115 biocidal Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 2
- 201000009890 sinusitis Diseases 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000000811 xylitol Substances 0.000 claims 2
- 235000010447 xylitol Nutrition 0.000 claims 2
- 206010001076 Acute sinusitis Diseases 0.000 claims 1
- 229940057801 Calcium Lactate Pentahydrate Drugs 0.000 claims 1
- 229940113118 Carrageenan Drugs 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-Threitol Natural products OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 claims 1
- 239000004386 Erythritol Substances 0.000 claims 1
- 229940009714 Erythritol Drugs 0.000 claims 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N Erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 1
- 229960001031 Glucose Drugs 0.000 claims 1
- HPVJXNNKHRNBOY-UHFFFAOYSA-L calcium;2-hydroxypropanoate;pentahydrate Chemical compound O.O.O.O.O.[Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O HPVJXNNKHRNBOY-UHFFFAOYSA-L 0.000 claims 1
- 239000000679 carrageenan Substances 0.000 claims 1
- 235000010418 carrageenan Nutrition 0.000 claims 1
- 229920001525 carrageenan Polymers 0.000 claims 1
- 230000001684 chronic Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 235000019414 erythritol Nutrition 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 235000001727 glucose Nutrition 0.000 claims 1
- 239000000644 isotonic solution Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 229960001407 sodium bicarbonate Drugs 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
Claims (13)
- 約0.01重量/容量%〜約15重量/容量%の量のκ−カラゲナンと、担体溶液とを含む組成物であって、前記担体溶液が、約35mM未満の低イオン強度を有する等張溶液である、組成物。
- 第2の活性薬剤をさらに含む、請求項1に記載の組成物であって、前記第2の活性薬剤が、抗ウイルス剤、抗生物質、抗真菌剤、抗炎症剤および抗酸化剤からなる群から選択される、組成物。
- 前記κ−カラゲナンの量が、約0.12重量/容量%である、請求項1または2に記載の組成物。
- 前記担体溶液の量が、約50mL〜約350mLである、請求項1〜3のいずれか1項に記載の組成物。
- 前記担体溶液が、NaClおよびKClを含む、請求項1〜4のいずれか1項に記載の組成物。
- 前記担体溶液が、乳酸カルシウム五水和物、重炭酸ナトリウム、グルコース、キシリトール、エリスリトールまたは希釈剤のうちの1種または複数種をさらに含む、請求項5に記載の組成物。
- キットであって、粉末状の治療量のκ−カラゲナン、約35mM未満の低イオン強度を有する等張担体溶液を調製するために再構成される粉末、およびそれらの使用説明書を含み、前記κ−カラゲナンが、約0.01重量/容量%〜約15重量/容量%の量である、キット。
- 陽圧洗浄装置をさらに含む、請求項7に記載のキット。
- 治療有効量のκ−カラゲナンおよび担体溶液の使用であって、前記担体溶液が、約35mM未満の低イオン強度を有する等張溶液であり、および前記κ−カラゲナンが、上気道の疾患または状態の治療のための薬剤の調製において約0.01重量/容量%〜約15重量/容量%の量である、使用。
- 前記κ−カラゲナンの量が、約0.12重量/容量%である、請求項9に記載の使用。
- 前記薬剤が、第2の活性薬剤をさらに含み、前記第2の活性薬剤が、抗ウイルス剤、抗生物質、抗真菌剤、抗炎症剤および抗酸化剤からなる群から選択される、請求項9または10に記載の使用。
- 治療されるべき前記疾患または状態が、非アレルギー性鼻炎、アレルギー性鼻炎、急性副鼻腔炎、アレルギー性と非アレルギー性との両病因による鼻副鼻腔炎および慢性鼻副鼻腔炎を含む群から選択される、請求項9〜11のいずれか1項に記載の使用。
- 約0.01重量/容量%〜約15重量/容量%の量のκ−カラゲナンと、担体溶液とを含む組成物であって、前記担体溶液が、約35mM未満の低イオン強度を有する等張溶液であり、および前記担体溶液が、キシリトールをさらに含む、組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2016900553A AU2016900553A0 (en) | 2016-02-17 | Compositions and Methods for the Treatment of Sinus Diseases and Disorders | |
AU2016900553 | 2016-02-17 | ||
PCT/AU2017/050144 WO2017139854A1 (en) | 2016-02-17 | 2017-02-17 | Compositions and methods for the treatment of sinus disease and disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019505538A JP2019505538A (ja) | 2019-02-28 |
JP2019505538A5 true JP2019505538A5 (ja) | 2020-03-19 |
Family
ID=59624790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018542227A Pending JP2019505538A (ja) | 2016-02-17 | 2017-02-17 | 副鼻腔疾患および障害の治療のための組成物と方法 |
Country Status (13)
Country | Link |
---|---|
US (1) | US11357791B2 (ja) |
EP (1) | EP3416655A4 (ja) |
JP (1) | JP2019505538A (ja) |
KR (1) | KR20180108811A (ja) |
CN (1) | CN108697731A (ja) |
AU (1) | AU2017220396B2 (ja) |
BR (1) | BR112018016651A2 (ja) |
CA (1) | CA3013942C (ja) |
HK (1) | HK1258884A1 (ja) |
IL (1) | IL261134B2 (ja) |
SG (1) | SG11201806835SA (ja) |
WO (1) | WO2017139854A1 (ja) |
ZA (1) | ZA201806103B (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180108811A (ko) | 2016-02-17 | 2018-10-04 | 이엔티 테크놀로지스 피티와이 리미티드 | 부비강 질환 및 장애의 치료를 위한 조성물 및 방법 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3563194B2 (ja) * | 1996-03-15 | 2004-09-08 | 株式会社ノエビア | 塩化ナトリウム含有ゲル組成物及びその製造方法 |
JPH11189533A (ja) * | 1997-12-25 | 1999-07-13 | Taisho Pharmaceut Co Ltd | 点眼薬 |
US6214376B1 (en) * | 1998-08-25 | 2001-04-10 | Banner Pharmacaps, Inc. | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
US6518244B2 (en) * | 2000-03-09 | 2003-02-11 | Intimax Corporation | Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof |
JP2002302448A (ja) * | 2001-04-02 | 2002-10-18 | Shiseido Co Ltd | 皮膚外用剤 |
CN1491724A (zh) * | 2003-09-02 | 2004-04-28 | 无锡杰西医药科技有限公司 | 一种适用于青光眼治疗的成胶增稠用多糖系统 |
EP1930015A1 (en) | 2006-12-05 | 2008-06-11 | Marinomed Biotechnologie GmbH | Use of carrageenan for treating rhinovirus infections |
US20080317791A1 (en) | 2007-06-25 | 2008-12-25 | Cp Kelco U.S., Inc. | Kappa Carrageenan |
JP2011219412A (ja) * | 2010-04-09 | 2011-11-04 | Saisentan Igaku Kenkyusho:Kk | 緑内障の視野改善治療薬 |
AU2012212385B2 (en) | 2011-02-02 | 2015-01-15 | Ent Technologies Pty Ltd | Compositions and methods for the treatment of nasal passages |
WO2012126777A1 (en) | 2011-03-18 | 2012-09-27 | Marinomed Biotechnologie Gmbh | Inhibition of neuraminidase activity |
WO2014123880A1 (en) | 2013-02-05 | 2014-08-14 | The Population Council, Inc. | Intravaginal ring for the delivery of unique combinations of antimicrobial compositions |
CA2932237C (en) * | 2013-12-03 | 2022-12-13 | Gerolymatos International S.A. | Ionic aqueous compositions comprising sulfated polysaccharides |
WO2015114622A1 (en) * | 2014-01-28 | 2015-08-06 | Resdevco Research And Development Co. Ltd. | Composition comprising xylitol and cholecalciferol for topical treatment of skin and mucous membranes |
DE102015110674A1 (de) | 2015-07-02 | 2017-01-05 | Sms Group Gmbh | Umbausystem für einen Elektrolichtbogenofen (EAF) |
DK3370692T3 (da) * | 2015-07-14 | 2023-06-26 | Marinomed Biotech Ag | Sammensætning til frigørelse af tilstoppet næse med antiviral aktivitet |
KR20180108811A (ko) | 2016-02-17 | 2018-10-04 | 이엔티 테크놀로지스 피티와이 리미티드 | 부비강 질환 및 장애의 치료를 위한 조성물 및 방법 |
-
2017
- 2017-02-17 KR KR1020187025908A patent/KR20180108811A/ko unknown
- 2017-02-17 EP EP17752579.7A patent/EP3416655A4/en not_active Withdrawn
- 2017-02-17 CA CA3013942A patent/CA3013942C/en active Active
- 2017-02-17 CN CN201780014521.4A patent/CN108697731A/zh active Pending
- 2017-02-17 SG SG11201806835SA patent/SG11201806835SA/en unknown
- 2017-02-17 BR BR112018016651A patent/BR112018016651A2/pt not_active Application Discontinuation
- 2017-02-17 US US15/998,565 patent/US11357791B2/en active Active
- 2017-02-17 JP JP2018542227A patent/JP2019505538A/ja active Pending
- 2017-02-17 AU AU2017220396A patent/AU2017220396B2/en active Active
- 2017-02-17 WO PCT/AU2017/050144 patent/WO2017139854A1/en active Application Filing
-
2018
- 2018-08-13 IL IL261134A patent/IL261134B2/en unknown
- 2018-09-12 ZA ZA2018/06103A patent/ZA201806103B/en unknown
-
2019
- 2019-01-25 HK HK19101357.4A patent/HK1258884A1/zh unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018193377A5 (ja) | ||
HRP20191871T1 (hr) | Ionski vodeni pripravci | |
JP2014505733A5 (ja) | ||
JP2015509788A5 (ja) | ||
JP2009542581A5 (ja) | ||
RU2008152341A (ru) | Применение аллопуринола для лечения ладонно-подошвенной эритродизестезии | |
JP2011518838A5 (ja) | ||
JP2014518275A5 (ja) | ||
JP2006501133A5 (ja) | ||
JP2018523635A5 (ja) | ||
BR112015018252A2 (pt) | composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit | |
JP2014516942A5 (ja) | ||
JP2016534142A5 (ja) | ||
JP2020524689A5 (ja) | ||
JP2017105861A5 (ja) | ||
JP2009544665A5 (ja) | ||
JP2017105859A5 (ja) | ||
JP2017002035A5 (ja) | ||
JP2020138980A5 (ja) | ||
WO2018005801A3 (en) | Novel non-systemic tgr5 agonists | |
JP2020517665A5 (ja) | ||
WO2018005794A3 (en) | Novel non-systemic tgr5 agonists | |
RU2017145271A (ru) | Терапевтическое средство для фиброза | |
JP2014508758A5 (ja) | ||
JP2019505538A5 (ja) |